IDT Australia Limited
IDT.AX
Get informed when a big investor buys or sells
+ FollowMarket Cap$16.24M
Close$
Share Statistics
| Market cap | $16.24 Million |
|---|---|
| Enterprise Value | $27.18 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.01 |
| Beta | 0.93 |
| Outstanding Shares | 425,722,544 |
Return
| Return on Equity | -56.62% |
|---|---|
| Return on Assets | -30.90% |
| Return on Invested Capital | -30.85% |
Valuation & Multiples
| P/E Ratio | -5.94 |
|---|---|
| PEG | 8.37 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.68 |
| Enterprise Value to EBIT | -3.01 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.5 |
| Debt to Equity | 0.71 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 19, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
February 23, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About IDT Australia Limited
156 employees
CEO: Mark Simari IDT Australia Limited is an enterprise deeply involved in the entire lifecycle of pharmaceutical products, from initial research and development through to manufacturing and global distribution of both active pharmaceutical ingredients (...